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A novel echocardiographic 
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Giuseppe Ristagno1, Roberto Latini1 & Lidia staszewsky1
Cardiac Magnetic Resonance (CMR) is the gold standard for left ventricular (LV) function assessment in 
small rodents and, though echocardiography (eCHo) has been proposed as an alternative method, LV 
volumes may be underestimated when marked eccentric remodeling is present. In the present study we 
described a novel echocardiographic method and we tested the agreement with CMR for LV volumes 
and ejection fraction calculation in mice with experimental myocardial infarction. sham-operated 
and infarcted mice, subjected to Coronary Artery Ligation, underwent eCHo and CMR. Volumes and 
ejection fraction were calculated by ECHO using a standard Simpson’s modified method (ECHO pLAX) 
or a method from sequential parasternal short axis (ECHO pSAX) acquired mechanically by translating 
the probe every 1 mm along the left ventricle. The mean differences ±1.96 standard deviation near to 
zero suggested close agreement between ECHO pSAX and CMR; contrarily ECHO pLAX agreement 
with CMR was lower. In addition, ECHO was three times shorter and cheaper (Relative cost difference: 
pLAX: −66% and pSAX −57%) than CMR. In conclusion, ECHO pSAX is a new, fast, cheap and accurate 
method for LV function assessment in mice.
Wild-type and genetically manipulated mice are widely used in experimental models of myocardial infarction 
to examine the characteristics of cardiac phenotype, the role of a specific protein, or to test in vivo the efficacy of 
new therapeutic approaches1. The functional response of the murine heart to any intervention can now be studied 
in vivo using several non-invasive imaging techniques2. To date, the two most widely used imaging methods are 
echocardiography (ECHO) and Cardiac Magnetic Resonance (CMR).
Echocardiography is a simple, fast, cheap and safe imaging method3. In the last two decades, it has been 
the most frequently used technique to assess left ventricular (LV) structure and function in mice. New 
high-resolution instruments have now been designed, specifically to study small rodents, using high-frequency 
probes (30–50 MHz) with higher spatial resolution (30 µm), allowing more accurate assessment of the left ventri-
cle2,3. However, the main limits of this method are its geometric assumptions, the acoustic window characteris-
tics, probe positioning errors, and a highly subjective approach that makes a skilled sonographer indispensable3. 
Moreover, despite echocardiography is the routine imaging method used for non-invasive left ventricular func-
tion assessment in small rodents, a systematic critical evaluation of imaging quality and of the resulted data, is 
often lacking.
Cardiac Magnetic Resonance is the gold standard for non-invasive assessment of cardiac function in small 
rodents4–6. With the strength of its significant intrinsic contrast and not dependent on geometric assumptions, it 
allows the acquisition of contiguous slices of short-axis images along the entire length of the left ventricle, per-
mitting accurate estimates of LV volumes (LVVs). Although CMR is the most reliable method, with the highest 
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sensitivity and specificity to study the heart anatomy in vivo, it is expensive and fairly time-consuming compared 
to ECHO, which why it is not routinely used in large series of animals or for serially repeated exams4–6.
Several studies have proposed new ECHO approaches for assessing cardiac function, in order to avoid the 
limits of the standard left chamber quantification in small rodents4,7–9. One of these methods is the echocardio-
graphic 3D reconstruction of the left ventricle4, which has been found to have good agreement with CMR for Left 
Ventricular Ejection Fraction (LVEF) calculation in several clinical studies10. However, it is not widely used, and 
is still not available in most of the experimental laboratories.
Another general crucial issue is that stringent and robust comparisons between ECHO and CMR in the setting 
of pharmacological preclinical research not specialized in imaging are still necessary.
Here we investigated whether an echocardiographic approach which allows acquiring serial short-axis images 
using a high-resolution ultrasound system allows a better agreement with CMR for LV function assessment in a 
mouse model of myocardial infarction.
Methods
All supporting data are available within the article and upon reasonable request to the corresponding author.
Animal use and care. Mice were housed at constant room temperature of 23 °C and relative humidity 
(60 ± 5%) with ad libitum access to food and water and fixed 12 hours light/dark cycle. Procedures involving 
animals and their care were conducted in conformity with the institutional guidelines at the Mario Negri Institute 
for Pharmacological Research IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) in compliance with 
national (D.lgs 26/2014; Authorization no. 19/2008-A issued March 6, 2008 by the Ministry of Health of Italy) and 
international (European Economic Community Council Directive 2010/63/UE; the National Institutes of Health 
Guide for the Care and Use of Laboratory Animals, 2011 edition) laws and policies. Procedures were reviewed and 
approved by the Mario Negri Institute Animal Care and Use Committee, which includes ad hoc members for 
ethical issues, and by the Italian Ministry of Health (Decreto no. 62/2012-B). Animal facilities meet international 
standards and are regularly checked by a certified veterinarian who is responsible for health monitoring, animal 
welfare supervision, experimental protocols, and review of procedures.
surgical procedures. A total of 25 C57BL/6J mice (body weight ranging 23–31 g) were anesthetized with 
isoflurane and permanent occlusion was induced by Coronary Artery Ligation (CAL), as previously described11. 
In 16 sham-operated mice (SHAM) surgery was done without CAL with the suture placed loosely around the left 
coronary artery. All animals received buprenorphine (0.1 mg/kg s.c. q12h) for one day as post-surgical analgesia 
and were followed for six weeks. Mortality was constantly recorded until six weeks after surgery. Mortality rate in 
CAL mice was 28% (n = 18 survived) while all SHAM mice (n = 16) reached the end of the follow up.
ECHO: Image acquisition. Echocardiography was performed using a 30 MHz mechanical probe with a 
spatial resolution of 30 µm (VisualSonics, Vevo 770, Toronto, Canada) 6 weeks after CAL on mice anesthetized 
with isoflurane (0.5–1.5% in O2). Animals were positioned on a rail system for maintenance of the body temper-
ature (37 °C ± 0.5 °C) and the probe position under electrocardiographic (EKG) and respiratory monitoring for 
the entire duration of the exam.
Parasternal long-axis (pLAX) B-mode image was acquired, optimizing the LV length for LV volume measure-
ments and ejection fraction calculations (Fig. 1A). Parasternal short-axis (pSAX) 2D images of the left ventricle 
were recorded by translating the probe every 1 mm from the base to the apex (Fig. 1B). Cine loops containing 
five cardiac cycles (25–35 frames per cardiac cycle at a frame rate of 300–400/sec) were stored in Digital Imaging 
and COmmunications in Medicine (DICOM) format and measurements were taken off-line.
ECHO: LV volumes and ejection fraction calculation. Measurements were made off line by two sonog-
raphers (I.R., L.S.) blinded to experimental groups. LV endocardial areas were drawn manually in end-diastolic 
and end-systolic frames in images from pLAX and pSAX views. LV end-diastolic and end-systolic volumes 
(LVEDV and LVESV) were calculated using two methods: (1) a standard Single-plane modified Simpson 
(ComPACS software, Medimatic S.R.L, Genoa, Italy) from the pLAX view (ECHO pLAX, Fig. 2A); (2) from the 
pSAX view acquiring sequential short-axis 1 mm-thickness slices covering the entire left ventricle (ECHO pSAX, 
Fig. 2B). Diastolic and systolic endocardial areas were drawn manually in each slice and volumes were calculated 
with the formula used in CMR12,13 as follows: Σ(LVEDA) or Σ(LVESA)*slices thickness (LVEDA, end-diastolic 
area; LVESA, end-systolic area). Ejection fraction was calculated following the formula: (LVEDV-LVESV)/
LVEDV*100. For each parameter, the mean of 3–5 consecutive measurements was calculated.
CMR: Image acquisition. Cardiac Magnetic Resonance was done three days after ECHO on a horizontal 
bore 7 Tesla USR preclinical MRI system (BioSpec 70/30, BrukerBioSpin, Germany) with a shielded gradient 
insert (BGA 12, 400mT/m; rise time 110 ms). A linear volume coil and anatomically shaped surface coil were 
used to transmit/receive the magnetic resonance signals (linear volume coil inner diameter, 72 mm; surface coil 
inner diameter, 10 mm, Bruker BioSpin, Germany). After the localizer, scans (segmented double-gated FLASH 
imaging) were run to ensure correct positioning, tuning and matching the probe; slice-selective shimming and 
flip angle calibration were done manually before each experiment. Cine-MRI pulse-sequences were: matrix 
256 × 128; FOV 40.0 × 20.0 mm; echo time, 2.98 ms; flip angle 15°; slice thickness, 1 mm; number of averages, 6; 
repetition time, 12 ms.
Mice, anesthetized by facemask with isoflurane (at the same concentration used in ECHO) and 0.3 L/min O2, 
were positioned in a purpose-built cradle and EKG electrodes were attached to the front paws. A pressure trans-
ducer for respiratory gating was positioned above the abdomen. A fiber optic probe was used to monitor the rectal 
temperature. EKG and respiratory signals were processed and displayed using a gating device and temperature 
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was maintained at 37 ± 0.5 °C throughout the examination (SA Instruments, Stony Brook, NY Model 1025 MRI 
compatible physiological monitoring system).
After the image plane orientation from the coronal, sagittal and axial LV long-axis, a vertical long axis (VLA) 
was obtained and, orthogonal to it, adjusting orientation from a short axis slice at the mid-papillary muscle level, 
a horizontal long axis (HLA) was acquired followed by 1 mm serial short-axis slices covering the entire LV length 
(Fig. 2C). Six to eleven short-axis slices were acquired from base to apex. Sixteen frames per slice for one cine 
sequence were stored (two cardiac cycles) to ensure the acquisition of maximum and minimum LV expansion 
(end-diastole and end-systole). Images were exported in DICOM format and analyzed off-line.
CMR: LV volumes and ejection fraction calculation. Two investigators (I.R., L.S.) blinded to the 
experimental conditions analyzed CMR recordings. End-diastolic and end-systolic parameters were measured 
in selected frames respectively according to the visual estimation of the maximal and minimal ventricular cavity. 
End-diastolic and end-systolic endocardial areas of each slice were traced manually. LV volumes and ejection 
fraction were calculated using the CMR formula.
All echocardiographic and CMR examinations were included in the analysis if they presented at least five dis-
tinct sequential short-axis slices where epicardial and endocardial borders were adequately visualized.
In vivo measurement of infarct size. Infarct size was calculated in vivo by CMR considering the areas 
of akinesis. In the end-diastolic frames, the epicardial and endocardial circumferences were traced separately 
from the length of the infarcted tissue5. Three to five short-axis views were considered from the first slice that 
showed an akinetic segment to the last one to obtain a measurement of infarct size applying the formula: Σ (Iepi/
Tepi + Iendo/Tendo)*100]/n slices (Tepi and Tendo = total epicardial and endocardial circumference of left ventricle; Iepi 
and Iendo = epicardial and endocardial length of infarcted tissue). Infarct size is expressed as percentage of the left 
ventricle.
sample size calculation and statistical analysis. For sample size calculation, we assumed that the mean 
difference (µ), the standard deviation of difference (σ) and the predefined clinical limits of agreement (δ) between 
ECHO and CMR in LVEF values should not have been greater than −0.3 ± 8.2%, with 95% limits of agreement 
between −16.4 and 15.7; these values are based on our experience and are also considered clinically plausible10. 
According to the above statement, we calculated an approximate sample size of 19 mice per group in order to 
apply the Bland and Altman method with a non-central t-distribution assuming a two-side α error of 0.05% and 
a power of 80%14. In addition, considering a six weeks mortality rate of 30% in CAL mice, the number of animals 
to include in the CAL group was 25.
Figure 1. ECHO pLAX and ECHO pSAX methods. Schematic representation of ECHO pLAX (A) and ECHO 
pSAX (B) acquisition. (A) 2D ECHO cine-loops were taken from parasternal long axis view and endocardial 
diastolic and systolic areas were traced according to the maximal and minimal LV expansion. (B) transducer 
was rotated approximately 90 degrees clockwise from the parasternal long axis until left ventricle appeared 
circular. Serial cine-loops of 2D images from parasternal short axis view were acquired from base to apex by 
translating the ultrasound probe by 1 mm using a customized system. The figure was drawn using Servier 
Medical Art (https://smart.servier.com).
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Data are expressed as mean ± standard error (SE). Differences between two groups were analyzed for statisti-
cal significance with an unpaired Student’s t-test. Correlations (r) between CMR and echocardiographic measure-
ments and between infarct size and LV volumes and ejection fraction measured by ECHO and CMR were tested 
by Pearson’s method. Limits of agreement between imaging methods were established as the mean difference 
(bias) ±1.96 standard deviation (SD) of the differences, as described by Bland and Altman15,16. We calculated 95% 
Figure 2. ECHO and CMR images. In vivo echocardiographic images of infarcted heart taken from 2D 
parasternal long axis (A) and from serial consecutive parasternal short axis (B) and used to apply the ECHO 
pLAX and the ECHO pSAX methods, respectively. Both echocardiographic methods were used to calculate LV 
volumes and ejection fraction and were compared to CMR (C). Corresponding ex-vivo photographs of anterior 
and posterior walls of the left ventricle in corresponding animals are presented in the bottom of the panel. AW, 
anterior wall; FW, free wall; IVS, interventricular septum; LV, left ventricle; PW, posterior wall; HLA, horizontal 
long axis; MID-PAP, mid-papillary level; VLA, vertical long axis. *Indicates papillary muscles.
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limits of agreement for means and mean differences as 1.96*SD. Statistical significance was set at 5% (Graph Pad 
Prism 6.0).
The reproducibility of ECHO pLAX, ECHO pSAX and CMR for LV volumes and ejection fraction measure-
ments was evaluated by calculating the intra-observer and inter-observer variability in both SHAM and CAL 
groups. Variability was defined as the absolute difference between the corresponding repeated measurements 
for each animal and expressed as percentage of their mean as represented in the following formula17,18: % var-
iability = (measure 1-measure 2/average of measure 1 and measure 2)*100. The resulted data are expressed as 
mean ± SD.
Results
In vivo data. Six weeks after surgery body weight (BW) was not different in CAL and SHAM mice (Table 1). 
Although CMR total acquisition time was three-times longer than ECHO (CMR 68 mins vs. ECHO 23 mins, 
Fig. 3), the duration of the CMR and ECHO exams was similar in SHAM and CAL mice (CMR: 60 mins and 
65 mins, ECHO: 23 mins and 22 mins, respectively). The heart rate did not differ either between the two groups 
(Table 2).
In mice with CAL, infarct size ranged between 11.4% and 69.1% (mean value = 40.2 ± 3.3%, Table 1), LVEDV 
was 2.2 times greater in CAL compared with SHAM mice (p < 0.05), LVESV resulted 5.0 times greater and LVEF 
was 2.2-fold lower (p < 0.05). Mean values of LV parameters studied are presented in Table 2.
Heart weight and the ratio of heart weight to body weight were significantly higher in CAL than SHAM mice 
(+27%, p < 0.0001 and +24%, p < 0.001,) (Table 1).
Agreement between eCHo and CMR. In SHAM mice, the mean of differences between ECHO pLAX 
and CMR and ECHO pSAX and CMR for LVVs and LVEF was close to zero (Fig. 4A,B and Table 3). The smaller 
range of 95% limits of agreement when ECHO pLAX (−3.2–16.8%) was compared to CMR indicated that this 
method was more accurate than ECHO pSAX (−20.6–14.0%) for LVEF calculation in SHAM mice (Fig. 4A,B).
In CAL mice, ECHO pLAX underestimated LVVs (Fig. 4C), particularly LVESV (mean difference ± SD 
11.5 ± 38.22 μL, Table 3). When ECHO pSAX was compared to CMR, the mean differences were close to zero for 
all studied parameters (Table 3) and the 95% limits of agreement showed a consistently smaller variation of the 
differences (Fig. 4D).
Correlation between CMR and eCHo. As shown in Supplementary Fig. 1, in SHAM mice the correla-
tion between LVVs and LVEF measured by ECHO and those obtained by CMR was not significant. In contrast, 
in CAL animals there was a significant linear correlation between LVVs and LVEF calculated by CMR with the 
values given by each of the ECHO methods used in the study.
SHAM CAL
n 16 18
BW (g) 26.2 ± 0.8 26.6 ± 0.5
HW (mg) 109.4 ± 3.0 137.9 ± 4.4#
HW/BW 4.2 ± 0.1 5.2 ± 0.5§
Infarct size (%) 40.2 ± 3.3
Table 1. In vivo data. Abbreviations: CAL, Coronary Artery Ligation; n, number of animals; BW, body weight; 
HW, heart weight. P value from Student t-test: #p < 0.0001 vs. SHAM; §p < 0.001 vs. SHAM.
Figure 3. Acquisition time. Comparison between ECHO and CMR imaging duration considering all 34 
animals. Data are expressed as mean ± SE. P value from Student’s t-test.
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Inter- and intra-observer variability. The inter-observer and intra-observer variability in LVEDV, LVESV 
and LVEF calculation in SHAM and CAL mice for all studied imaging methods (Table 4) showed that all three 
methods are reproducible. In SHAM mice, a slightly higher percentage of inter-observer variability was observed 
for LVESV measurements in CMR and ECHO pLAX. In the CAL group, only small differences between observers 
were found and were higher for LVEDV measurements in CMR and ECHO pSAX and for LVESV in CMR.
Discussion
In the present study we have showed a close agreement between an accessible and fast echocardiographic method, 
the ECHO pSAX, and the gold standard CMR for LV volumes and ejection fraction calculation in mice with myo-
cardial infarction. This finding has valuable implications in the experimental setting, particularly for longitudinal 
studies and animal welfare. In mice with a non-asymmetric left ventricle, ECHO pLAX measurements agree 
closely with those of CMR, thus this standard ECHO method might be confirmed as a fast and accurate approach 
for assessing systolic function in non-infarcted left ventricles.
This study showed, for the first time to our knowledge, the accuracy of a new high-resolution echocardio-
graphic method of simple manual use for LV volumes and ejection fraction calculation in a large number of mice 
with myocardial infarction. Our data confirm previous results obtained by two independent studies with smaller 
number of mice and the use of an echocardiographic machine equipped with a 7/15 MHz linear-array probe4,7.
Echocardiography with high spatial resolution (30μm) along with an ad hoc instrument for LV scanning 
allowed contiguous cross-sectional segmentation of the left ventricle and more appropriate comparison between 
ECHO and CMR (Figs 1 and 2)
A customized hardware/software interface was developed in the last generation of echocardiographic 
machines in order to control the motor stage holding the ultrasound transducer and trigger the scanner to acquire 
and store data. This tool allowed for the automatic acquisition of finely sampled 2D short‐axis loops providing for 
a 3D assessment of the left ventricle.
As well known, the quantification of LV remodeling through LV volumes and ejection fraction measurements 
is useful for assessing the severity of LV injury, establishing the prognosis7 and studying the response to a specific 
treatment. Even if it is widely accepted that in an asymmetric left ventricle LV volumes and ejection fraction 
calculation is less accurate if derived from M-mode or from 2D long-axis view, these methods are the most fre-
quently and routinely used in experimental settings.
Recently a 3D echocardiographic method has been published with a customized hardware/software interface 
developed to control a motor stage that holds the ultrasound transducer and trigger the scanner for the acquisi-
tion of serial sampled 2D short‐axis loops. This method was used to measure LV volumes and ejection fraction in 
mice with myocardial infarction but, to our knowledge, any correlation data and/or agreement was provided with 
CMR, the gold standard method to evaluate LV function19.
A recent study20 has compared ECHO and CMR in CAL mice by using echocardiographic serial slices 
obtained from parasternal long axis view. Interestingly the results showed an agreement in LV volumes and ejec-
tion fraction measurements between the studied methods which was similar to what has been found in our study, 
particularly for ejection fraction calculation, using the ECHO pLAX method (mean difference: 3.4% vs. 3.8%; 
95% limits of agreement: −16.9–23.6 vs. −17.5–25.1, Fig. 4). However the agreement observed with ECHO pSAX 
in our study was closer (mean difference: −0.3%; 95% limits of agreement: −16–16, Fig. 4).
Our validation suggests that ECHO pLAX can be proposed as the elective method for LV volumes and ejec-
tion fraction calculation in symmetrical ventricles. LV ejection fraction in mice was slightly higher by ECHO 
pLAX compared to CMR (mean difference ± SD: 6.8 ± 5.1%, Table 3). This might be ascribed to long-axis peak 
velocities during systole which are slightly higher and rather homogeneous distributed in LV segments in mice 
SHAM CAL P values
HR (bpm)
CMR 493 ± 12 463 ± 15 NS
ECHO 460 ± 19 444 ± 16 NS
LVEDV (µl)
CMR 48.6 ± 6.0 108.1 ± 12.3 <0.01
ECHO pLAX 48.9 ± 1.7 102.3 ± 5.3 <0.01
ECHO pSAX 46.4 ± 2.4 112.0 ± 12 <0.01
LVESV (µl)
CMR 16.0 ± 0.7 79.3 ± 11.6 <0.01
ECHO pLAX 12.9 ± 1.0 67.8 ± 4.8 <0.01
ECHO pSAX 16.4 ± 1.3 82.0 ± 11.4 <0.01
LVEF (%)
CMR 67.1 ± 1.0 30.0 ± 2.8 <0.01
ECHO pLAX 73.9 ± 1.4 33.9 ± 2.1 <0.01
ECHO pSAX 63.6 ± 2.2 29.8 ± 2.3 <0.01
Table 2. CMR and ECHO parameters in SHAM and CAL mice. Data are shown as mean ± SE; Abbreviations: 
bpm, beats per minute. LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic 
volume; LVEF, left ventricular ejection fraction. P values from Student’s t-test.
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compared to the radial and the rotational, according to Jung et al.21 by phase contrast CMR and/or to the difficulty 
in the identification of endocardial borders, particularly at apical sections. The echocardiographic underesti-
mation of LV volumes compared to CMR is already known22,23. CMR is more accurate than ECHO in tracing 
end-diastolic areas with its better definition of the endocardium and easier exclusion of the papillary muscles and 
trabeculae. This might explain the wide limits of agreement between ECHO pSAX and CMR for LV volumes and 
ejection fraction calculation. We wonder whether these differences are acceptable: similar results were reported 
in humans where the limits of agreement for ejection fraction were −18.1–8.3% between ECHO (measured from 
apical 4-chamber and 2-chamber, views applying the biplane modified Simpson’s method) and CMR23 and even 
greater in rats when measurements were taken from the 2D parasternal long-axis and from a single 2D short-axis 
at the mid-papillary level9.
Bland and Altman analysis confirmed that the accuracy of ECHO pSAX, compared to ECHO pLAX, was 
closer to CMR. Moreover, since ECHO is 3-fold faster (Fig. 3) and cheaper (Supplementary Table 1) than CMR, 
even using a self-gating acquisition scheme24, ECHO pSAX should be a reliable alternative for studying the LV 
systolic function in mice with myocardial infarction. It is clear that ECHO pSAX can be only used in anesthetized 
mice and echocardiographic machine must be equipped with high-resolution ultrasound and a mechanical sys-
tem to move the probe in order to obtain sequential slices. As mentioned before, similar approach was recently 
used by O’Connor DM and colleagues19 who measured LV volumes and ejection fraction in mice with reperfused 
myocardial infarction using an ultrasound system, with the same resolution as we used but equipped with a cus-
tomized hardware/software interface for automatic acquisition.
Figure 4. Bland and Altman plots for SHAM and CAL mice. The agreements between CMR and ECHO pLAX 
(A,C) and between CMR and ECHO pSAX (B,D) in SHAM and CAL mice are presented. See corresponding 
Table 3 for each mean difference. Single CMR and ECHO parameters are presented in Table 2.
SHAM CAL
ECHO pLAX ECHO pSAX ECHO pLAX ECHO pSAX
LVEDV (µl) −0.3 ± 9.4 −3.7 ± 10.9 −5.3 ± 37.3 3.8 ± 33.7
LVESV (µl) −3.2 ± 4.6 0.4 ± 5.9 −11.5 ± 38.2 2.8 ± 25.5
LVEF (%) 6.8 ± 5.1 −3.5 ± 8.7 3.8 ± 10.9 −0.3 ± 8.2
Table 3. Bland-Altman. Agreement between ECHO methods and CMR. Data are shown as mean 
difference ± SD.
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It is debated whether ECHO pLAX is a valuable method for assessing LV function in experimental models 
of myocardial infarction4. We found a small mean difference and acceptable 95% limits of agreement between 
ECHO pLAX and CMR for LV ejection fraction but not for LV volumes (Fig. 4). These results suggest that without 
a high-resolution ultrasound platform, the ECHO pLAX method can be used for LV ejection fraction calculation 
in mice with myocardial infarction, but LV volumes will be underestimated.
We found no statistical significance in the correlation between ECHO pLAX and CMR measurements in 
SHAM mice possible because the values were concentrated in a very narrow range (Supplementary Fig. 1).
We wondered if ECHO pSAX method could be applied to other species used as models in cardiovascular 
research. Two and four apical chambers views are recommended by the echocardiographic guidelines to accu-
rately assess LV volumes and ejection fraction (particularly in asymmetric ventricles) by using the biplane 
method of disk summation technique25. Here we proposed the ECHO pSAX method because of the impossibility 
to obtain standardized and non-foreshortened apical views in mice, the experimental myocardial infarction most 
used animal model. Based on our experience, ECHO pSAX method could be used to evaluate rats, whereas its 
applicability on other species such as rabbits and feline would need further analysis. In large models like dogs and 
pigs, the use of two and four apical chambers views has been reported by our group and others26,27, and is fully 
accepted as standard method for LV volumes and ejection fraction calculation. However, our method could be an 
alternative to use in those animals with a non-optimal apical window.
As already mentioned, scan time during CMR may explain the higher LV volumes observed. In order to 
expedite CMR procedure, in the last few years, new coils with higher signal-to-noise ratios (SNR) using parallel 
elements and/or cryocooling techniques have been developed28. Only one study in rats29 has used a 4-element 
array. Clearly due to the different cardiac dimensions between rats and mice, the SNR and the image quality 
obtained in that study cannot be compared with that obtained in our experimental setup. In the present study, the 
CMR acquisition could have been shortened by using an under sampling of the k-space; however, this procedure 
reduces the SNR of the image and could have produced image distortions. The prospectively triggered acquisi-
tion on EKG signal is also time-consuming. The introduction of cardiac and respiratory self-gated (Intragate®) 
acquisition with retrospective reconstruction of the cardiac cycle24 could have shortened the CMR acquisition. 
Unfortunately, it may be optimal for assessing normal cardiac hearts but may give an inaccurate analysis in 
infarcted animals. First, the decrease in SNR and in the contrast-to-noise ratio between blood and myocardial 
wall may be challenging in the identification of the endocardial borders of the thin infarcted wall; second it may 
not be able to consider the possible arrhythmias and EKG disorders that can arise in CAL mice. Another issue 
to underline is that we saved 16 frames per cardiac cycle for accurate detection of end-diastole and end-systole 
phases, and this latter takes part in the total acquisition time.
Inter-observer 
variability, %
Intra-observer 
variability, %
EDV
ECHO LAX SHAM 2.3 ± 5.9 0.9 ± 2.0
ECHO SAX SHAM −4.2 ± 1.4 0.2 ± 2.0
CMR SHAM −0.2 ± 2.6 2.3 ± 1.5
ESV
ECHO LAX SHAM −4.4 ± 6.2 0.6 ± 3.9
ECHO SAX SHAM −0.1 ± 8.9 −0.5 ± 2.2
CMR SHAM −6.2 ± 8.0 1.9 ± 3.5
LVEF
ECHO LAX SHAM 0.2 ± 6.6 0.7 ± 2.6
ECHO SAX SHAM 0.4 ± 3.6 0.8 ± 2.4
CMR SHAM 2.9 ± 3.7 −0.8 ± 3.3
EDV
ECHO LAX CAL 0.3 ± 3.1 0.1 ± 4.4
ECHO SAX CAL 3.1 ± 3.7 1.9 ± 2.4
CMR CAL 3.7 ± 3.15 1.3 ± 3.2
ESV
ECHO LAX CAL 1.2 ± 2.5 −0.4 ± 6.8
ECHO SAX CAL 1.8 ± 6.5 1.0 ± 3.9
CMR CAL 3.1 ± 5.4 3.1 ± 3.4
LVEF
ECHO LAX CAL 2.9 ± 7.5 0.2 ± 4.7
ECHO SAX CAL 0.28 ± 8.2 2.6 ± 6.6
CMR CAL 2.0 ± 6.7 2.1 ± 5.5
Table 4. Variability. Inter-observer and intra-observer variability in ECHO pLAX, ECHO pSAX and CMR for 
left ventricular parameters studied.
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study Limitations
In mice with severe impairment of LV function, a reduced inflow effect may lower the contrast-to-noise ratio 
affecting the accuracy of our measurements, as described by other authors30. However, a significant correlation 
was found between myocardial infarction size measured by CMR and LV volumes and ejection fraction meas-
ured by all methods studied with a positive association with LV volumes and a negative association with ejection 
fraction (Supplementary Fig. 2).
Since mice with large myocardial infarction are likely to be affected by repeated anesthesia2, we adopted a 
three days interval after ECHO before CMR to allow for the reestablishment of vital parameters and ambulatory 
behavior and this could have affected the actual agreement between the two imaging methods31.
We are not able to suppose whether ECHO pSAX method may improve the echocardiographic assessment 
of LV remodeling in different experimental models without marked variations in LV geometry (i.g hypertrophic 
cardiomyopathies -such as aortic banding or transgenic mice-, HFpEF models, etc). In non-dilated left ventricles, 
the identification of the apical end-systolic endocardial border was difficult due to the superimposition of local 
irregularities of the mural endocardium. We suppose that this issue is the reason why ECHO pLAX method 
showed better agreement with CMR.
LV mass is also an overall important variable of LV remodeling. However, several works32,33, have showed sig-
nificant correlation between echocardiographic LV mass and crude LV weight in normal and post-aortic banding 
mice but not in myocardial infarction models. In dilated infarcted hearts, in fact, hypertrophy may be severe but 
may be masked by the thinning of the left ventricular wall thus the actual low LV weight may mask the presence 
of hypertrophic segments explaining the absence of correlation between LV mass and LV weight in myocardial 
infarction models. For this latter reason we did not include LV mass as variable in our study.
In the last few years hardware has made great improvements in CMR field. The new cryocoils, with their gain 
in the SNR, between 3.0–5.034, have greatly reduced the CMR scanning time (namely 6 times faster) but this is still 
a costly hardware upgrade which is not always feasible.
Conclusions
LV volumes and ejection fraction measured by ECHO pSAX and CMR were very similar. This result has impor-
tant practical implications in experimental settings, since ECHO is more readily available. However, ECHO pLAX 
remains a reliable method for LV function assessment of symmetrical left ventricle and for LV ejection fraction 
calculation in infarcted mice.
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